Grow Access Project Cannabis Clinics Review
Our Rating: 4/5
Company site: https://growgroupplc.com/
Email: hello@growgroupplc.com
CQC: Here
HIS License: Here
Virtual Consultations: Available
In-Person Consultations: Available
Participating Clinics: Integro Clinics, IPS Pharma
Partner Schemes: Project Twenty21, Sapphire Access Scheme, Grow Access Project
GAP (Grow Access Project) Discounts:
- Initial Consultations for GAP Patients: Free
- Discount on GROW Flowers: £6.50/g to £7/g
- Discounts on Follow-Ups and Repeat Prescriptions at the Participating Clinics
(Brands of cannabis medications can be prescribed through the scheme but will be subject to the standard RRP to patients) (Grow does not prescribe the same medical cannabis that Releaf does, however, Releaf prescribes the same cannabis).
Cannabis is not included, you must get it from the pharmacy.
It does not include any devices or items needed to start your cannabis treatment.
What is Grow Access Project?
Grow Access Project is a Patient Access Scheme that enables the patients of the participating clinics to access GROW-branded cannabis flowers at discounted prices.
Integro Clinics and IPS Pharma are the leading clinics that are a part of this Project. The patients of these clinics can get discounts and prescribed cannabis medicines at lowered prices.
Eligible Grow Flowers:
- Grow Pharma T22:C1 LA SAGE Medical Cannabis
- Grow Pharma T18:C1 Gelato Medical Cannabis
- Grow Pharma T18:C1 Herijuana Medical Cannabis
- Grow Pharma T22:C1 Hellfire OG Medical Cannabis
- Grow Pharma T20–22 Strawberry Glue Medical Cannabis
- Grow Pharma T16:C1 Herijuana Medical Cannabis
- Grow Pharma T20–22 French Cookies Medical Cannabis
Eligibility Criteria
The GAP initiative is meant to provide affordable cannabis medicines to patients with chronic illnesses and pain. Since cannabis flowers are becoming popular for pain relief and other safe medicinal properties, their legal use has become rampant in the UK. The GAP scheme, in particular, aims at helping low-income UK locals and veterans (UK mainland residents only) to access legal cannabis medicines at lowered prices.
Through online registration and questionnaires, the eligibility of the patients can be accessed. Once it is established, they can get GROW-branded flowers and their GROW medicines at very lowered rates. However, patients registered at the participating clinics for over three months are not eligible for the free consultation; they would be required to go through the eligibility first.
What Is Unique About GAP?
The first 500 GAP patients from the participating clinics can get a free initial consultation. The prices for flowers range between £6.50/g to £7/g which makes them accessible to almost anyone. Patients from the participating clinics also largely benefit from the reduced follow-up and repeat prescriptions.
Grow Access Project is also a part of the LVL Clinical trials. These trials are a result of extensive research-based evidence regarding the safe use of cannabis for medical purposes. CANPAIN study is the latest and most prominent study conducted under LVL Trials regarding the safety, tolerability, and effectiveness of a cannabis-based medicinal product (CBMP) for the treatment of chronic non-cancer pain.
Getting access to safe, legal, and affordable cannabis has become quite difficult in the UK. With the ongoing rise in prices and lack of easy access to legalised medicines, UK locals have largely depended on the use of cannabis-based medicines for long-term recovery from chronic illnesses. Thus, patient access schemes like GAP are helping patients to a large extent.
